Condition: Ankylosing Spondylitis · Sponsor: Tasly Pharmaceutical Group Co., Ltd
The goal of this clinical trial is evaluating the efficacy and safety of Jitongning tablets in participant population. The main questions it aims to answer are: * Based on the proportion of participants who achieved improvement in ASAS20, evaluate whether the efficacy of Jitongning tablets is superior to placebo in active ax-SpA adult participants. * Evaluate the efficacy of Jitongning tablets in improving other key functions and symptom outcomes. * Evaluating the safety of Jitongning tablets in adult ax-SpA participants. Participants will 1. take orally Jitongning tablets or a simulated agent of Jitongning tablets. 2. Receive examinations and follow-up visits.
This description comes directly from the study's public registry record.
Wei Liu · 022-27432680 · fengshiliuwei@163.com
Always discuss trial participation with your own doctor first.
| Dongfang Hospital, Beijing University of Chinese Medicine | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Hospital of Traditional Chinese Medicine, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Recruiting |
| The First Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Suzhou Hospital of Traditional Chinese Medicine | Suzhou, Jiangsu, China | Recruiting |
| Affiliated Hospital of North Sichuan Medical College | Nanchong, Sichuan, China | Recruiting |
| The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine | Tianjin, Tianjin Municipality, China | Recruiting |
| Yunnan Province Hospital of Traditional Chinese Medicine | Kunming, Yunnan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06000956